Results of the use of the drug Superlymph® in the treatment of chronic cystitis according to clinical studies
About 30 million cases of urinary tract infections (UTI) are registered annually in the Russian Federation. An important feature of UTI is the tendency for their recurrent course, which significantly worsens the quality of life of patients. In addition, it increases the number of cases of temporary disability, which determines the socio-economic significance of UTI. Normalization of the human immune status plays an important role in the prevention of relapses of chronic diseases. Superlymph® is a natural complex of natural antimicrobial peptides and cytokines, which are universal stimulants of the immune system secreted by leukocytes of the peripheral blood of pigs. In addition to the immunomodulatory effect, Superlymph® has antiviral, antimicrobial and fungicidal properties. A review of data from 7 clinical studies of the use of Superlymph® in patients with chronic cystitis with a total number of more than 800 participants is presented in the article. The results demonstrated that the drug Superlymph® allows to relieve more effectively symptoms of exacerbations of chronic cystitis, increases the duration of the relapse-free period, improves microcirculation of the urethra and vagina, and reduces the severity of inflammation in the bladder.Perepanova T.S., Pozdnyakov N.O., Khokhlov A.A.
Keywords
chronic cystitis
Superlymph®
postcoital cystitis
dysuria
ACSS
About the Authors
Corresponding author: N.O. Pozdnyakov – Ph.D., assistant at the Basic Department of Innovative Pharmacy of the FGBOU VO Yaroslavl State Medical University of the Ministry of Health of the Russia, Chief of the Department of Clinical Research, AX CT LLC, Yaroslavl, Russia; e-mail: pozdnyakov.niko@yandex.ruSimilar Articles
